Essential Medicines for Universal Health Coverage

7 November 2016

Policy

Medicines for Europe’s Contribution to WHO’s Biological Qualifier (BQ) Developments (PRESENTATION and SPEECH)

18 October 2016

Policy

      18 October 2016 Suzette Kox Senior Director […]

Understanding the Science of Extrapolation and Defining Interchangeability – Dr. Elena Wolff-Holz, EULAR Symposium London

10 June 2016

Policy

Value Added Medicines: Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

31 May 2016

Policy, Report

EGA-EBG Summary Position Regarding the WHO Biologic Qualifier Proposal (INN Working Doc. 14.342)

21 March 2016

Policy

Biosimilar Product Labelling

2 February 2016

Policy

The value of generic medicines

26 November 2015

Policy

Read more about the value of generic medicines PDF version or […]

EGA-EBG Considerations on WHO’s BQ Proposal – Suzette Kox, WHO INN Open Session with Stakeholders, Geneva, 13 October 2015 (PPT)

13 October 2015

Policy

Investing in People Centred Health Service Delivery – Paul Cornes, Riga Health Conference – How to Improve Health Systems Through Technology? 29-30 June 2015, Riga, Latvia (PPT)

29 June 2015

Policy

Launch of European Value Added medicines (EVA), a new EGA sector group, will deliver efficiency

12 June 2015

Policy

Brussels – The European Generic and Biosimilar medicines Association (EGA) announced […]